AstraZeneca has entered a strategic research partnership with China’s CSPC Pharmaceutical Group in a deal worth up to $5.3 billion, reinforcing the Anglo-Swedish biopharmaceutical giant’s ambitions to accelerate AI-powered drug…
RegtechAfrica
Tunisia will host the first MENA Regional “One Health” Conference on June 14–15, 2025, marking a landmark step in advancing coordinated action across health, agriculture, and environmental sectors to address…
GSK has announced that the European Medicines Agency (EMA) is currently reviewing its application to expand the approved use of its respiratory syncytial virus (RSV) vaccine, Arexvy, to include adults…
The U.S. Food and Drug Administration (FDA) has granted expanded approval for Moderna’s respiratory syncytial virus (RSV) vaccine, mRESVIA, authorising its use in adults aged 18 to 59 who are…
Cleveland Clinic Abu Dhabi has successfully conducted the UAE’s first robotic cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC), marking a major milestone in the country’s surgical and oncological capabilities.…
European Union member states have endorsed a European Commission proposal to restrict Chinese medical device manufacturers from participating in EU public procurement tenders, following findings of systemic barriers faced by…
The U.S. Food and Drug Administration (FDA) has officially launched Elsa, a generative artificial intelligence (AI) platform developed in-house to enhance operational efficiency, particularly in scientific and regulatory review processes.…
Argentina’s government has announced plans to reevaluate the fast-track authorization process for high-cost medications and tighten clinical trial standards for vaccines, as part of a broader overhaul of national healthcare…
The future of healthcare is no longer reactive—it’s predictive. A new wave of innovation, led by smart devices and powered by artificial intelligence (AI), is transforming the global healthcare landscape.…